Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma

por Brown, Michael P, Ebert, Lisa M, Gargett, Tessa
Publicado 2019

Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma

por Brown, Michael P, Ebert, Lisa M, Gargett, Tessa
Publicado 2021

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma

por Gardam, Bryan, Gargett, Tessa, Brown, Michael P., Ebert, Lisa M.
Publicado 2023

Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies

por Truong, Nga T. H., Gargett, Tessa, Brown, Michael P., Ebert, Lisa M.
Publicado 2021

New approaches to model glioblastoma in vitro using brain organoids: implications for precision oncology

por Gomez, Guillermo A., Oksdath, Mariana, Brown, Michael P., Ebert, Lisa M.
Publicado 2019

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy

por Yeo, Erica C. F., Brown, Michael P., Gargett, Tessa, Ebert, Lisa M.
Publicado 2021

Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response

por Scheer, Kaitlin G., Ebert, Lisa M., Samuel, Michael S., Bonder, Claudine S., Gomez, Guillermo A.
Publicado 2023

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

por Ebert, Lisa M., MacRaild, Sarah E., Zanker, Damien, Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Publicado 2012

Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?

por Tan, Lih Yin, Martini, Carmela, Fridlender, Zvi G, Bonder, Claudine S, Brown, Michael P, Ebert, Lisa M
Publicado 2017

DeepSurvNet: deep survival convolutional network for brain cancer survival rate classification based on histopathological images

por Zadeh Shirazi, Amin, Fornaciari, Eric, Bagherian, Narjes Sadat, Ebert, Lisa M., Koszyca, Barbara, Gomez, Guillermo A.
Publicado 2020

CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix

por Martini, Carmela, DeNichilo, Mark, King, Danielle P., Cockshell, Michaelia P., Ebert, Brenton, Dale, Brian, Ebert, Lisa M., Woods, Anthony, Bonder, Claudine S.
Publicado 2021

Platelets disrupt vasculogenic mimicry by cancer cells

por Martini, Carmela, Thompson, Emma J., Hyslop, Stephanie R., Cockshell, Michaelia P., Dale, Brian J., Ebert, Lisa M., Woods, Anthony E., Josefsson, Emma C., Bonder, Claudine S.
Publicado 2020

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.

por Tan, BeeShin, Anaka, Matthew, Deb, Siddhartha, Freyer, Claudia, Ebert, Lisa M., Chueh, Anderly C., Al-Obaidi, Sheren, Behren, Andreas, Jayachandran, Aparna, Cebon, Jonathan, Chen, Weisan, Mariadason, John M.
Publicado 2013

Vasculogenic mimicry structures in melanoma support the recruitment of monocytes

por Tan, Lih Y., Cockshell, Michaelia P., Moore, Eli, Myo Min, Kay K., Ortiz, Michael, Johan, M. Zahied, Ebert, Brenton, Ruszkiewicz, Andrew, Brown, Michael P., Ebert, Lisa M., Bonder, Claudine S.
Publicado 2022

Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma

por Kollis, Paris M., Ebert, Lisa M., Toubia, John, Bastow, Cameron R., Ormsby, Rebecca J., Poonnoose, Santosh I., Lenin, Sakthi, Tea, Melinda N., Pitson, Stuart M., Gomez, Guillermo A., Brown, Michael P., Gargett, Tessa
Publicado 2022

A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties

por Pitman, Melissa R., Powell, Jason A., Coolen, Carl, Moretti, Paul A.B., Zebol, Julia R., Pham, Duyen H., Finnie, John W., Don, Anthony S., Ebert, Lisa M., Bonder, Claudine S., Gliddon, Briony L., Pitson, Stuart M.
Publicado 2015

A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma

por Lenin, Sakthi, Ponthier, Elise, Scheer, Kaitlin G., Yeo, Erica C. F., Tea, Melinda N., Ebert, Lisa M., Oksdath Mansilla, Mariana, Poonnoose, Santosh, Baumgartner, Ulrich, Day, Bryan W., Ormsby, Rebecca J., Pitson, Stuart M., Gomez, Guillermo A.
Publicado 2021

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma

por Ebert, Lisa M., Vandyke, Kate, Johan, M. Zahied, DeNichilo, Mark, Tan, Lih Y., Myo Min, Kay K., Weimann, Benjamin M., Ebert, Brenton W., Pitson, Stuart M., Zannettino, Andrew C. W., Wallington‐Beddoe, Craig T., Bonder, Claudine S.
Publicado 2021

Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy

por Pickering, Chad, Aiyetan, Paul, Xu, Gege, Mitchell, Alan, Rice, Rachel, Najjar, Yana G., Markowitz, Joseph, Ebert, Lisa M., Brown, Michael P., Tapia-Rico, Gonzalo, Frederick, Dennie, Cong, Xin, Serie, Daniel, Lindpaintner, Klaus, Schwarz, Flavio, Boland, Genevieve M.
Publicado 2023

Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome

por Tan, Lih Yin, Mintoff, Chris, Johan, M. Zahied, Ebert, Brenton W., Fedele, Clare, Zhang, You Fang, Szeto, Pacman, Sheppard, Karen E., McArthur, Grant A., Foster-Smith, Erwin, Ruszkiewicz, Andrew, Brown, Michael P., Bonder, Claudine S., Shackleton, Mark, Ebert, Lisa M.
Publicado 2016